BUZZ-Insilico hits fresh high on milestone payment from Menarini Group

Reuters02-03
BUZZ-Insilico hits fresh high on milestone payment from Menarini Group

** Shares of biotech group InSilico Medicine Cayman TopCo 3696.HK jump 14% to HK$68.7, fresh high since December 30 debut

** Stock on track for biggest daily gain since Jan 12; snapping 2-day decline

** InSilico receives HK$39 mln (about $5 mln) milestone payment from Menarini Group after first-in-patient dosing in Phase I trial of cancer drug MEN2501

** Total licensing deal with Menarini's Stemline Therapeutics Inc exceeds $550 mln value

** Stock has soared 186% from HK$24.05 IPO price in just over 3 weeks

** YTD, stock is up 82.3%, Hang Seng Biotech Index .HSBIO up 5.3%

($1 = 7.8124 Hong Kong dollars)

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment